Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Reliance Infrastructure Limited - Updates

2018-07-21 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Reliance Infrastructure Limited - Option to submit Standalone/Consolidated Financial Results

2018-06-29 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
RInfra gets MERC approval for deal with Adani Transmission

2018-06-28 livemint
New Delhi: Reliance Infrastructure (RInfra) on Thursday said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100% stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs18,800 crore.
500390 RELINFRA 532662 RELEY RIFS 539254 HTMEDIA RIFA RELFF ADANITRANS

0
MERC approves sale of RInfra#39;s Mumbai power biz to Adani Transmission

2018-06-28 moneycontrol
Reliance Infrastructure today said the Maharashtra Electricity Regulatory Commission (MERC) has approved the 100 percent stake sale in its integrated Mumbai power business to Adani Transmission Ltd (ATL) for an estimated value of Rs 18,800 crore. "Following the commission's nod, the transaction is expected to be closed in July 2018. The MERC had concluded its hearing into the matter and reserved its order on June 14, 2018," it said in a BSE filing.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Reliance Infrastructure Limited - Press Release

2018-06-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Steady cash flows, low risk make power transmission segment a safe bet

2018-06-24 livemint
Mumbai: With over 22,000 megawatts (MW) of installed power capacity starved of coal and natural gas supplies, power generation is no longer the hot investment target it used to be. What is taking its place—where everybody now wants a piece of the action—is last-mile delivery of power: transmission.
GKO RELEY TATAPOWER RIFS 539254 RELFF 500390 RELINFRA TPCL RIFA 522287 KALPATPOWR 500400 ADANITRANS

17
MFs offloaded shares in PowerGrid, InterGlobe Aviation in May

2018-06-20 thehindubusinessline
Suresh P Iyengar The mutual fund industry has offloaded 22 per cent of Power Grid Corporation shares worth ₹1,905 crore in May, as prospects of the company looked bleak with no major new power project being launched and a sharp decline in power generation.
RIFS 532617 HCTHY TTQQY TATACHEM 500390 PIDILITIND PDLTY 532281 HDFCBANK 500770 500331 INDIGO RELEY IBN RELFF JETAIRWAYS 535322 REPCOHOME 539448 RELINFRA ICICIBANK HDB 532174 500180 HCLTECH RIFA 534809 PCJEWELLER

12
93% land acquired for Mumbai-Nagpur Expressway: Devendra Fadnavis

2018-06-18 freepressjournal.in
Mumbai: Maharashtra has completed 93 per cent of land acquisition for the 700-km Mumbai- Nagpur Expressway, according to chief minister Devendra Fadnavis. “In less than 12 months, the state has acquired 93 per cent of the land needed to build the Mumbai-Nagpur 700-km super communication highway with 24 nodes or interchanges that will be developed as smart cities along its path,” American brokerage Morgan Stanley said in a note quoting the chief minister as saying.
RELEY RIFS MS.PRE MS.PRF RELFF MS.PRG MS.PRA 500390 RELINFRA MS.PRI MS.PRK RIFA MS

0
MMRDA evaluating bids from IL&FS, Reliance Infrastructure for Mumbai monorail

2018-06-18 freepressjournal.in
Mumbai: The Mumbai Metropolitan Region Development Authority (MMRDA) is evaluating bids submitted by IL&FS and Anil Ambani’s Reliance Infrastructure for handling operations and maintenance of the country’s first monorail.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
The Maharashtra Electricity Regulatory Commission reserves order on RInfra-Adani deal

2018-06-14 moneycontrol
The Maharashtra Electricity Regulatory Commission (MERC) today concluded its hearing on the proposed sale of Reliance Infrastructure's Mumbai power distribution business to Adani Transmission for an estimated Rs 18,800 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Merc reserves order on Reliance Infra-Adani Transmission deal

2018-06-14 freepressjournal.in
Mumbai: The Maharashtra Electricity Regulatory Commission (Merc) today concluded its hearing on the proposed sale of Reliance Infrastructure’s Mumbai power distribution business to Adani Transmission for an estimated Rs 18,800 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

0
Mumbai: MMRDA begins soil testing for Metro 4 corridor construction

2018-06-05 freepressjournal.in
Mumbai: The Mumbai Metropolitan Region Development Authority (MMRDA) began construction on the metro corridor connecting Wadala-Ghatkopar-Thane-Kasarvadavali on Monday with soil testing work at the area near Bhakti Park at Wadala and planning for traffic diversion along the route. This Metro 4 corridor will be constructed simultaneously in five packages after contractors were appointed in March this year.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
13 lowest bidders named for Samruddhi Mahamarg E-way

2018-06-01 freepressjournal.in
Maharashtra State Road Development Corporation (MSRDC) Authorities’ announced 13 lowest bidders (L-1) out of 18 eligible financial bidders to construct 13 packages of the 700-km Nagpur-Mumbai Maharashtra Samruddhi Mahamarg (MSM) Expressway.
500390 RELINFRA 539150 RELEY RIFS RIFA RELFF PNCINFRA

0
Reliance Infrastructure Limited - Updates

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

0
Reliance Infrastructure Limited - Committee Meeting Updates

2018-05-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...